Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.

肺癌中表皮生长因子受体的突变及对靶向治疗的敏感性。

youdao

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。

youdao

A total of 210 women with early breast cancer who tested positive for human epidermal growth factor receptor 2 (HER2) were enrolled.

共有210名患有人表皮生长因子受体2 (HER2)阳性的早期乳腺癌的女性患者参加了实验。

youdao

All three drugs target the epidermal growth factor receptor (EGFR), a protein that is over-expressed in cancer cells.

FORBES: Magazine Article

The public has mostly focused on Erbitux's ability to slow tumor growth by blocking epidermal growth factor receptor, a key growth-promoting protein that is overabundant in many cancer cells.

FORBES: Bristol, ImClone File On Erbitux